Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
HPV16 E6
Description:
HPV16 E6 is an oncoprotein encoded by human papillomavirus type 16 that contributes to viral persistence and cellular transformation.
Primary topic:
Cervical Cancer and HPV Research (42%)
Related topics:
Cervical Cancer and HPV Research (42%),
Cancer-related Molecular Pathways (9%)
OpenAlex ID:
keywords/hpv16-e6
Senescence of human fibroblasts induced by oncogenic Raf
1998
·
Jiyue Zhu
, Douglas Woods
, et al.
·
Genes & Development
·
925
PDF
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis
1996
·
Alan F. Wahl
, Karen L. Donaldson
, et al.
·
Nature Medicine
·
763
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
2016
·
Denise Martinez-Zapien
, Francesc Xavier Ruiz
, et al.
·
Nature
·
566
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
1995
·
M E Ressing
, A Sette
, et al.
·
The Journal of Immunology
·
418
Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer
2013
·
Randall J. Kimple
, Molly A. Smith
, et al.
·
Cancer Research
·
415
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
1994
·
R J Slebos
, M H Lee
, et al.
·
Proceedings of the National Academy of Sciences
·
391
Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation
1999
·
Daniela Gardiol
, Christian Kühne
, et al.
·
Oncogene
·
342
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
1996
·
D S Hawkins
, G W Demers
, et al.
·
PubMed
·
340
Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity
2008
·
Gemma G. Kenter
, Marij J.P. Welters
, et al.
·
Clinical Cancer Research
·
331
T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
2019
·
Stacey L. Doran
, Sanja Stevanović
, et al.
·
Journal of Clinical Oncology
·
307
PDF
Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53‐mediated repression of transcription.
1992
·
M.S. Lechner
, D.H. Mack
, et al.
·
The EMBO Journal
·
295
PDF
E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells
2009
·
T. Rampias
, C. Sasaki
, et al.
·
JNCI Journal of the National Cancer Institute
·
294
The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells
1992
·
C L Halbert
, G W Demers
, et al.
·
Journal of Virology
·
290
PDF
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
2001
·
N Keshelava
, J J Zuo
, et al.
·
PubMed
·
271
Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer
2012
·
Toshiyuki Sasagawa
, Hiroaki Takagi
, et al.
·
Journal of Infection and Chemotherapy
·
258
Inverse Relationship between Human Papillomavirus-16 Infection and Disruptivep53Gene Mutations in Squamous Cell Carcinoma of the Head and Neck
2008
·
William H. Westra
, Janis M. Taube
, et al.
·
Clinical Cancer Research
·
254
PDF
p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.
1995
·
P A Havre
, J Yuan
, et al.
·
PubMed
·
223
The Human Papillomavirus Type 16 E6 Oncoprotein Activates mTORC1 Signaling and Increases Protein Synthesis
2010
·
Jennifer M. Spangle
, Karl Münger
·
Journal of Virology
·
218
Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells
1991
·
V Band
, J A De Caprio
, et al.
·
Journal of Virology
·
201
PDF
The Aurora Kinase Inhibitor VX-680 Induces Endoreduplication and Apoptosis Preferentially in Cells with Compromised p53-Dependent Postmitotic Checkpoint Function
2006
·
Farid Gizatullin
, Yao Yao
, et al.
·
Cancer Research
·
194
Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.
2003
·
Peter J Baldwin
, Sjoerd H van der Burg
, et al.
·
PubMed
·
194
E6 Proteins from Multiple Human Betapapillomavirus Types Degrade Bak and Protect Keratinocytes from Apoptosis after UVB Irradiation
2008
·
Michael P. Underbrink
, Heather L. Howie
, et al.
·
Journal of Virology
·
183
Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens.
1992
·
T. Crook
, K.H. Vousden
·
The EMBO Journal
·
163
Activated Notch1 Signaling Cooperates with Papillomavirus Oncogenes in Transformation and Generates Resistance to Apoptosis on Matrix Withdrawal through PKB/Akt
2001
·
Annapoorni Rangarajan
, Ruchi Syal
, et al.
·
Virology
·
162
Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells
2003
·
Takayuki Ikezoe
, Sophie Chen
, et al.
·
International Journal of Oncology
·
160
Show more works
View as search
Works count:
925
Citation count:
25,900
Year
Topic
Type